Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) (Q79215184)
Jump to navigation
Jump to search
scientific article published on 09 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) |
scientific article published on 09 October 2006 |
Statements
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) (English)
L Perey
R Paridaens
H Hawle
K Zaman
F Nolé
H Wildiers
M Fiche
D Dietrich
P Clément
D Köberle
A Goldhirsch
B Thürlimann
9 October 2006